Deric M. Park, M.D., FACP
Dr. Park is a staff clinician in the Neuro-Oncology Branch (NOB). He is a physician-scientist with training in clinical neuro-oncology and cell biology. His research goals are to translate basic research observations to the clinic to improve outcome for patients with brain tumors.
Open - Not yet RecruitingNCI Protocol ID NCI-17-C-0037Investigator Deric M. Park, M.D., FACPShare this trial: Referral Contacts
Contact Name Phone Number Christine Bryla 301-443-3441
A Randomized, Double-Blind, Phase 2 Trial of GI-6301 (Yeast-Brachyury Vaccine) Versus Placebo in Combination with Standard of Care Definitive Radiotherapy in Locally Advanced, Unresectable, Chordoma.Open - RecruitingNCI Protocol ID NCI-15-C-0118Investigator Deric M. Park, M.D., FACPShare this trial: Referral Contacts
Contact Name Phone Number Christine Bryla 240-760-6007
Dr. Park's research efforts are directed at better understanding the pathogenesis of brain tumors in order to develop more effective treatment strategies for patients. In addition to glioma/glioblastoma, he also investigates other types of brain tumors such as meningioma and chordoma. A particular area of interest involves ongoing work on how intratumoral hypoxia (low oxygen) alters cellular behavior.
Selected Key Publications
- Scientific Reports. 5: 7979, 2015. [ Journal Article ]
von Hippel-Lindau disease-associated hemangioblastomas are derived from embryologic multipotent cells.PLoS Medicine. 4: e60, 2007. [ Journal Article ]
- Scientific Reports. 3: 1095, 2013. [ Journal Article ]
- Oncogene. 28: 3949-59, 2009. [ Journal Article ]
- PLoS One. 10: e0134426, 2015. [ Journal Article ]
Dr. Park received his medical degree from Loma Linda University and completed his neurology residency at the University of Chicago, where he was selected by the faculty to serve as Chief Resident. He then trained in clinical neuro-oncology and performed research on paraneoplastic neurologic syndromes at the Memorial Sloan-Kettering Cancer Center with Dr. Jerome B. Posner. This was followed by five years as a Research Fellow at the National Institutes of Health. He has served on the faculties of the University of Pittsburgh and the University of Virginia. Dr. Park provides care for patients with brain tumors and investigates tumor biology with focus on intratumoral hypoxia. He is a recipient of the Merit Award and the Career Development Award from ASCO.
|Jinkyu Jung Ph.D.||Research Fellow|
|Ashlee Seldomridge B.S.||Postbaccalaureate Fellow (CRTA)|